Drug Index

Dolutegravir

 
print

Indication :

• It is an integrase inhibitor used in the treatment of HIV.


Dosing :

<30 kg: Safety not established.

30 kg-40 kg: 35 mg orally once a day.

>40 kg: 50 mg orally once a day.


Adverse Effect :

Hypercholesterolemia, hypertriglyceridemia and elevated liver transaminases, lipase, bilirubin, creatine kinase, blood sugar. Can cause arthralgia, myalgia.


Interaction :

Efavirenz, Fosamprenavir/Ritonavir, Tipranavir/Ritonavir, Rifampin: Give twice a day when using along with efavirenz, fosamprenavir/ritonavir, tipranavir/ritonavir, rifampin.


07/18/2019 11:51:26 Dolutegravir
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0